Virios therapeutics, inc. announces proposed public offering

Atlanta--(business wire)---- $viri #biotech--virios therapeutics, inc. (nasdaq: viri), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia, announced today that it intends to offer to sell shares of its common stock in an underwritten public offering. all of the shares of common stock are to be sold by the company. the company intends to use the net proceeds from the offering primarily to further advan
VIRI Ratings Summary
VIRI Quant Ranking